TrialInternational journal of cancer2022

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).

Nicholas D James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.